Identification of prognostic factors in patients with diffuse large B-cell lymphoma.

To identify prognostic factors for patients with diffuse large B-cell lymphoma (DLBCL), specifically those classified into conflicting subgroups by Hans' and Choi's classification algorithms. We retrospectively reviewed clinical and pathological data of 154 patients diagnosed with de novo DLBCL in t...

Descripción completa

Detalles Bibliográficos
Publicado en:Indian Journal of Pathology & Microbiology Vol. 60; no. 1; pp. 87 - 92
Autores principales: Fang Peng, Liang Guo, Wei-Kai Yao, Yan Zheng, Ye Liu, Xiu-Mei Duan, Yin-Ping Wang, Peng, Fang, Guo, Liang, Yao, Wei-Kai, Zheng, Yan, Liu, Ye, Duan, Xiu-Mei, Wang, Yin-Ping
Formato: Journal Article
Publicado: Wolters Kluwer India Pvt Ltd Jan-Mar2017
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=121285920&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 121285920
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        03774929
        50DI
      jtl: Indian Journal of Pathology & Microbiology
      issn: 03774929
      maglogo: N
    pubinfo:
      dt: Jan-Mar2017
      vid: 60
      iid: 1
      pid: 16919
      pub: Wolters Kluwer India Pvt Ltd
    artinfo:
      ui:
        121285920
        121285920
        NLM28195099
        10.4103/0377-4929.200056
        NLM28195099
        121285920
      ppf: 87
      ppct: 5
      formats:
      tig:
        atl: Identification of prognostic factors in patients with diffuse large B-cell lymphoma.
      aug:
        au:
          Fang Peng
          Liang Guo
          Wei-Kai Yao
          Yan Zheng
          Ye Liu
          Xiu-Mei Duan
          Yin-Ping Wang
          Peng, Fang
          Guo, Liang
          Yao, Wei-Kai
          Zheng, Yan
          Liu, Ye
          Duan, Xiu-Mei
          Wang, Yin-Ping
        affil: Department of Pathology, The First Hospital of Jilin University, Changchun, China
      sug:
        subj:
          Prognosis
          Lymphoma, B-Cell Pathology
          Lymphoma, B-Cell Diagnosis
          Aged, 80 and Over
          Neoplasm Grading
          Female
          Survival Analysis
          Adult
          Proteins Analysis
          Retrospective Design
          Peptide Hydrolases Analysis
          Lymphoma, B-Cell Mortality
          Male
          Aged
          Middle Age
          Scales
          Aged, 80 & over
          Adult: 19-44 years
          Aged: 65+ years
          Middle Aged: 45-64 years
          Female
          Male
      ab: To identify prognostic factors for patients with diffuse large B-cell lymphoma (DLBCL), specifically those classified into conflicting subgroups by Hans' and Choi's classification algorithms. We retrospectively reviewed clinical and pathological data of 154 patients diagnosed with de novo DLBCL in the First Hospital of Jilin University from January 2004 to September 2011. All cases were classified into subgroups based on Hans' and Choi's algorithms with immunohistochemical markers.Statistical Analysis Used: The correlation between various clinicopathological factors and 5-year survival rate, the correlation between those factors with the International Prognostic Index, the concordance between Hans' and Choi's approach was evaluated. The survival in different subtypes as classified by Hans' or Choi's approach was mapped.Results: The Eastern Cooperative Oncology Group (ECOG) performance score 2-5, positive Bcl-2 expression, negative CD10 expression or negative Bcl-6 expression significantly correlated with worse prognosis. The two algorithms showed good consistency (83% concordance, Kappa = 0.660, P < 0.001). By both classifications, the 5-year overall survival rate in germinal center B-cell-like subtype (GCB) lymphoma is significantly higher than that in the non-GCB subtype. There were 25 cases assigned to conflicting subtypes by the two approaches. Among these 25 cases, ECOG 2-5, positive Bcl-2 expression, negative CD10 expression, or negative Bcl-6 expression significantly correlated with worse prognosis.Conclusions: ECOG 2-5, positive Bcl-2 expression, negative CD10 expression, or negative Bcl-6 expression are independent markers for poor prognosis of DLBCL patients. There were 15% cases assigned to conflicting subgroups based on the two algorithms. For these cases, ECOG 2-5, positive Bcl-2 expression, negative CD10 expression, or negative Bcl-6 expression still significantly correlate with poor prognosis.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N